Cardiac involvement in HIV-infected people living in Africa: A review

Cardiovascular Journal of South Africa

Volumn 14, Issue 5, 2003, Pages 231-237

  Magula, Nombulelo P ^a   Mayosi, Bongani M ^b  

^a UNIVERSITY OF NATAL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

AFRICA; CARDIOMYOPATHY; CLINICAL PRACTICE; CLINICAL TRIAL; CRYPTOCOCCOSIS; DISEASE ASSOCIATION; ECG ABNORMALITY; ECHOCARDIOGRAPHY; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MEDLINE; MORTALITY; MYOCARDITIS; OPPORTUNISTIC INFECTION; PERICARDIAL EFFUSION; PERICARDITIS; PRACTICE GUIDELINE; REVIEW; STEROID THERAPY; TOXOPLASMOSIS; TREATMENT OUTCOME; TUBERCULOSIS;

AFRICA; ECHOCARDIOGRAPHY; HEART DISEASES; HIV INFECTIONS; HUMANS;

EID: 0344443321     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. UNAID5. Aids epidemic update: December 2002. http://www.unaids.org/worldaidsday/2002/press/Epiupdate.html (accessed 01 March 2003).
2. Cohen IS, Anderson DW, Virmani R, et al. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med 1986; 315: 628-630.
3. Aciemo LJ. Cardiac complications in acquired immunodeficiency syndrome (AIDS): A review. J Am Coll Cardiol 1989; 12: 1140-1154.
4. Yunis NA, Stone VE. Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 145-154.
5. Silva-Cardoso J, Moura B, Martins L, Mota-Miranda A, Rocha-Goncalves F, Lecour H. Pericardial involvement in human immunodeficiency virus infection. Chest 1999; 115: 418-422.
6. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 2000; 160: 602-608.
7. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation 2002; 106: 1420-1425.
8. Levy WS, Simon GL, Rios JC, Ross AM. Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989; 63: 86-89.
9. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol 1989; 13: 1030-1036.
10. DeCastro S, Migliau G, Silvestri A, et al. Heart involvement in AIDS: a prospective study during various stages of the disease. Eur Heart J 1992; 13: 1452-1459.
11. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA. Heart muscle disease related to HIV infection: prognostic implications. BMJ 1994; 309: 1605-1607.
12. Herskowitz A, Vlahov D, Willoughby S, et al. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993; 71: 955-958.
13. Milei J, Grana D, Fernandez Alonso G, Matturri L. Cardiac involvement in acquired immunodeficiency syndrome - a review to push action. The Committee for the Study of Cardiac Involvement in AIDS. Clin Cardiol 1998: 21: 465-472.
14. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators. AIDS Res Hum Retroviruses 1998; 14: 1071-1077.
15. Barbaro G, Lipshultz SE, Pathogenesis of HIV-associated cardiomyopathy. Am N Y Acad Sci 2001; 946: 57-81.
16. Chariot P, Perchet H, Monnet I, et al. Dilated cardiomyopathy in HIV-infected patients, N Engl J Med 1999: 340: 732-735.
17. Hoffman MA, Lipshultz SE, Miller TL. Malnutrition and cardiac abnormalities in the HIV-infected patient. In: Miller TL, Gorbach SL, eds. Nutritional Aspects of HIV Infection. New York: Arnold, 1999: 133-139.
18. Herskowitz A, Willoughby S, Schulman SJ, Bartlett JD, Baughman KL. Cardiomyopathy in HIV-infected patients associated with antiretroviral therapy: a report of six cases. Ann Intern Med 1992; 116: 311-313.
19. Domanski MJ, Sloas MM, Follmann DA, et al. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr 1995; 127: 137-146.
20. Lipshultz SE, Orav EJ, Sanders SP, Colan SD. Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation 1995; 92: 2220-2225.
21. Barbaro G, Fisher SD, Pellicelli AM, Lipschultz SE. The expanding role of the cardiologist in the care of HIV infected patients. Heart 2001b; 86: 365-367.
22. Heidenreich PA, Eisenberg MJ, Kee LL, et al. Pericardial effusion in AIDS: incidence and survival. Circulation 1995; 92: 3229-3234.
23. Eisenberg MJ, Gordon AS, Schiller NB. HIV-associated pericardial effusions. Chest 1992; 102: 956-958.
24. Moreno R, Villacastin JP, Bueno H, et al. Clinical and echocardiographic findings in HIV patients with pericardial effusion. Cardiology 1997; 88: 397-400.
25. Holmberg SD, Moorman AC, Williamson JM, et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002; 360: 1747-1748.
26. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003; 348: 702-710.
27. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000; 40: 282-284.
28. Kuritzkes DR, Currier J. Cardiovascular risk factors and antiretroviral therapy. N Engl J Med 2003; 348: 679-680.
29. Nzuobontane D, Blackett KN, Kuaban C. Cardiac involvement in HIV infected people in Yaounde. Cameroon. Postgrad Med J 2002; 78: 679-691.
30. Malu K, Longo-Mbenza B, Lurhuma Z, Odio W. Pericarditis and acquired immunodeficiency syndrome [Article in French]. Arch Mal Coeur Vaiss 1988; 81: 207-211.
31. Bouramoue C, Oboa AS. Cardiopathies concommittantes avec le syndrome d'immunodeficience acquise. A propos de 20 cas. Cardiol Trop 1989; 15: 7-15.
32. Cegielski JP, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM. Pericardial disease and human immunodeficiency virus in Dar es Salaam. Tanzania. Lancet 1990; 335: 209-212.
33. Ogola EN, Ogutu EO. Pericardial disease in association with acquired immune deficiency syndrome. A report of two cases. Nairobi J Med 1990; 16: 3-4.
34. Taelman H, Kagame A, Batungwanayo J, et al. Pericardial effusion and HIV infection. Lancet 1990; 335: 924.
35. Bertrand ED. Coeur et SIDA, Preliminaires. Cardiol Trop 1992; 18: 128-129.
36. Longo-Mbenza B, Tonduangu K, Muvova D, Phuati MB, Seghers KV, Kestelot H. A clinical study of cardiac manifestations related to acquired immunodeficiency syndrome (AIDS) in Kinshasa. Arch Mal Coeur Vaiss 1995; 88: 1437-1443.
37. Cegielski JP, Lwakatare J, Dukes CS, et al. Tuberculous pericarditis in Tanzanian patients with and without HIV infection. Tuber Lung 1994; 75: 429-434.
38. Pozniak AL, Weinberg J, Mahari M, Neill P, Houston S, Latif A. Tuberculous pericardial effusion associated with HIV infection: a sign of disseminated disease. Tuber Lung Dis 1994: 75: 297-300.
39. Bouramoue C, Ekoba J. The heart and AIDS. Med Trop (Mars) 1996; 56: 33-39.
40. Hakim JG, Matenga JA, Siziya S. Myocardial dysfunction in human immunodeficiency virus infection: an echocardiographic study of 157 patients in hospital in Zimbabwe. Heart 1996; 76: 161-165.
41. Longo-Mbenza B, Tonduangu K, Seghers KV, Mubagwa D. HIV infection and pericardial disease invasion in Africa. Arch Mal Coeur Vaiss 1997; 90: 1377-1384.
42. Longo-Mbenza B, Tonduangu K, Kintonki Vita E, Seghers KV. The effect of HIV infection on high incidence of heart diseases in Kinshasa (Zaire). Echocardiographic study. Ann Cardiol Angeiol (Paris) 1997; 46: 81-87.
43. Maher D, Harries AD. Tuberculous pericardial effusion: a prospective clinical study in a low-resource setting - Blantyre, Malawi. Int J Tuberc Lung Dis 1997; 1: 358-364.
44. Longo-Mbenza B, Seghers LV, Vita EK, Tonduangu K, Bayekula M. Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study. Heart 1998; 80: 184-189.
45. Longo-Mbenza B, Seghers KV, Phuati M, Nkiabungu Bikangi F, Mubagwa K. Heart involvement and HIV infection in African patients: Determinants of survival. Int J Cardiol 1998: 64: 63-73.
46. Hakim JG, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000; 84: 183-188.
47. Niakara A, Kambire Y, Drabo YJ. Pericarditis in HIV infected patients: retrospective study of 40 cases in Ouagadougou, Burkina Faso. Sante 2001; 11: 167-172.
48. Niakara A, Drabo YJ, Kambire Y, Nebie LV, Kabore NJ, Simon F. Cardiovascular diseases and HIV infection: study of 79 cases at the National Hospital of Ouagadougou (Burkina Faso). Bull Soc Pathol Exot 2002; 95: 23-26.
49. Nzuobontane D, Ngu BK, Christopher K. Cardiovascular autonomic dysfunction in Africans infected with human immunodeficiency virus. J R Soc Med 2002; 95: 445-447.
50. Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ. Tuberculous pericarditis treatment (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software, 2002.
51. Mason JW, O'Connell JB. Clinical merit of endomyocardial biopsy. Circulation 1989; 79: 971-979.